BRL 44408 maleate salt, >=98% (HPLC)

Biochem/physiol Actions

BRL 44408 maleate is a selective α2A-adrenoceptor antagonist.

Features and Benefits

This compound is featured on the α2-Adrenoceptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Legal Information

Sold under agreement from GlaxoSmithKline

Packaging

10, 50 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Form Assay Price Quantity
3573281 BRL 44408 maleate salt, >=98% (HPLC) white to beige 100 DDIQGSUEJOOQQQ-BTJKTKAUSA-N 1S/C13H17N3.C4H4O4/c1-10-12-5-3-2-4-11(12)8-16(10)9-13-14-6-7-15-13;5-3(6)1-2-4(7)8/h2-5,10H,6-9H2,1H3,(H,14,15);1-2H,(H,5,6)(H,7,8)/b;2-1- SIGMA-ALDRICH powder ≥98% (HPLC)
£215.89 (exc VAT) per 10MG
-
+
3573282 BRL 44408 maleate salt, >=98% (HPLC) white to beige 100 DDIQGSUEJOOQQQ-BTJKTKAUSA-N 1S/C13H17N3.C4H4O4/c1-10-12-5-3-2-4-11(12)8-16(10)9-13-14-6-7-15-13;5-3(6)1-2-4(7)8/h2-5,10H,6-9H2,1H3,(H,14,15);1-2H,(H,5,6)(H,7,8)/b;2-1- SIGMA-ALDRICH powder ≥98% (HPLC)
£898.39 (exc VAT) per 50MG
-
+